HER-2 pulsed DC1 (ImmunoRestoration)

N/A

Report date: 2023/06/27 20:00:33

Base Information

Drug NameHER-2 pulsed DC1 (ImmunoRestoration)
Drug Alias NameHER2 Directed Dendritic Cell (DC1) Vaccine (Immunorestoration)
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmunorestoration
China Registration ClassN/A

Develop Information

Active CompaniesImmunorestorationH Lee Moffitt Cancer Center & Research Institute
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A